Respiratory system cancer (cancer of the nasal cavity, middle ear, paranasal sinuses (C30-31), larynx (C32), trachea, bronchi and lung (C33-34) is one of the most common malignancies in the Tomsk region, comprising 12.9% of all cancer cases. The purpose of the study was to analyze the respiratory system cancer incidence among the population of the Tomsk region. Materials and methods. The study was based on cancer register data collected at the Cancer Research Institute and Tomsk Regional Cancer Center, and covered the period 2005-2016. Results. Respiratory system cancer is the most common cancer in men, comprising 21.7% and the 6-th most common cancer in women, comprising 5.1. The incidence of respiratory system cancer decreased in men and showed an increasing tendency in women. The age-standardized incidence rates in the Tomsk region were expected to be 58.3 per 100,000 males and 12.8 per 100,000 females by 2020. Conclusion. Early detection and prediction of respiratory system cancer should play a vital role in the diagnosis process and also increase the survival rate of patient.

Between 2008 and 2017, 87 patients with lymphogenous metastasis from chondrosarcoma were treated at the Cancer Research Institute (Tomsk, Russia). Lymph node metastases were detected in 3 patients (3.4 %). All cases with lymphogenous metastases were characterized by the presence of the tumor in the appendicular skeleton, tumor extension beyond the bone with the formation of extraossal component, high-grade tumor (G2 and G3) and disease progression. Our study indicates the importance of the study of lymphogenous metastasis as evidence of an unfavorable outcome for chondrosarcoma. Further studies of risk factors for lymphogenous metastases and the mechanisms underlying lymphogenous metastasis will allow a better understanding of the phenomenon of lymphogenous metastasis.

Apart from smoking, an urban factor is an established risk factor for lung cancer. Lung cancer is associated with environmental factors, occupational exposure, bad habits and lifestyle factors. Approximately 17% of the annual deaths from lung cancer among adults are attributable to exposure to carcinogens located in the surface layer of the urban atmosphere, with industrial pollution and occupational hazards. According to recent data, 97% of cities in low- and middle-income countries with a population of more than 100 thousand people do not meet WHO recommendations for air quality; in high-income countries, this figure has been reduced to 49%. In the United States, the studies demonstrated that the prevalence of combined lung cancer was higher in urban areas (10.2%) than in rural areas (4.8%). There was a difference in the lung cancer incidence rates between the populations of the New York City and the New York State. In males, the lung cancer incidence rates were 1.4 times higher in the New York City than in the New York State (68.9 ± 1.2 0/0000 versus 48.5 ± 0.2 0/0000). In females, the lung cancer incidence rates were 1.2 times higher in the New York City than in the New York State (43.0 ± 0.3 and 34.9 ± 0.1 0/0000, respectively). In China, in urban areas, the lung cancer incidence mortality rates were 36.6 0/0000 and 28.9 0/0000, respectively. In rural areas, the corresponding values were 33.4 and 26.6 0/0000, respectively. Although the lung cancer incidence and mortality rates are higher in urban areas than in rural areas, these differences are gradually decreasing: the incidence rate between urban and rural areas has decreased from 2.1 to 1.1. The issue of the impact of environment on the incidence of lung cancer is challenging. The outdoor environment affects people’s health with varying degrees of intensity both in time and in space.

To study the diagnostic efficiency of single-photon emission computed tomography (SPECT) with 99mTc-MIBI 40 patients were chosen for diagnosing primary and recurrence of laryngeal or laryngopharyngeal cancer and as well as patients with benign diseases of the larynx. All patients underwent SPECT with 99mTc-MIBI. As a result it has been found that the sensitivity, specificity and accuracy of SPECT with 99mTc-MIBI in the diagnostics of primary tumors of the larynx are 95%, 80% and 92%, respectively. The visualization of recurrent tumors of the larynx and laryngopharynx has showed 100% sensitivity. The obtained results have proved the consistency of SPECT with 99mTc-MIBI as an additional method of diagnostics of <em>laryngeal and laryngopharyngeal</em> cancer.

One of the initiating mutations in the development of thyroid cancer is BRAF-V600E, which leads to the various signaling cascades activation and changes in the production of transcription and growth factors. It is known that papillary thyroid cancer is characterized by activation of the expression of transcription factors NF-kB and HIF-2a and AKT/m-TOR signaling cascade. However, the relationship of the studied molecular markers in patients with the wild and mutant BRAF gene has not yet been studied. The aim of the work was to study the expression of transcription factors NF-65B p65 and NF-kB p50, HIF-1a, HIF-2a, growth factors VEGF, CAIX and VEGFR2, components of the AKT/m-TOR signaling pathway in patients with thyroid papillary cancer depending on the presence of mutations BRAF-V600E. Material and methods. It was included 40 patients with papillary thyroid cancer with the stage of the tumor process T1-4N0-2M0. The expression of the indicators was determined by real-time PCR. BRAF-V600E mutation was revealed by allele-specific PCR in real-time. Results and discussion. It was found that patients with the absence and presence of the BRAF-V600E mutation had similar clinical and morphological parameters of the disease, which was accompanied by a change in the molecular-biological characteristics of the tumor. The presence of the mutant form of the gene in the tumor led to a decrease in the AKT, cRAF, GSK-3P kinases mRNA levels and the overexpression of NF-kB p65, HIF-1 and VEGF. Conclusion. Patients with papillary thyroid cancer have no differences in the clinical and morphological characteristics of the disease, depending on the status of the BRAF-V600E gene, is characteristic. It was identified biological parameters associated with this somatic mutation. An increase in the mRNA level of growth and transcription factors was observed with a decrease in the activity of the AKT / m-TOR signaling pathway.